Denosurel denosumab 120 mg Injection

Q: How should Denosurel denosumab 120 mg Injection be administered?

A: Denosurel is administered as a subcutaneous injection, usually in the upper arm, thigh, or abdomen by a qualified healthcare professional. The recommended dosage is 120 mg once every four weeks, following the instructions of your physician.

Q: What is the main benefit of using Denosurel Injection?

A: Denosurel helps prevent skeletal-related events such as fractures, spinal cord compression, or the need for radiation or surgery in adults with bone metastases from solid tumors, thereby enhancing quality of life in cancer patients.

Q: When should Denosurel Injection be used?

A: This injection is advised for adults diagnosed with bone metastases from solid tumors, or those at risk of skeletal complications as determined by their physician. It should be used according to medical advice and prescription schedules.

Q: Where should I store Denosurel Injection?

A: Denosurel should be kept in a cool, dry place away from heat and direct sunlight. Ensure the vial is stored at the recommended temperature and check the expiry date before use.

Q: What should I do if I miss a scheduled dose of Denosurel?

A: If you miss a dose, consult your physician as soon as possible to schedule the next injection. It is important to maintain regular dosing intervals for maximum efficacy.

Q: How is Denosurel Injection supplied and what is its shelf life?

A: Denosurel is supplied in a single-use vial containing 120 mg in 1.7 ml solution. Its shelf life is 24 months from the manufacturing date when stored correctly.

Q: What type of medication is Denosurel and who manufactures it?

A: Denosurel is a biopharmaceutical monoclonal antibody produced by Reliance Life Sciences Pvt. Ltd. It is available by prescription for use in adults with certain cancer-related bone conditions.